FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/02/017432 [Registered on: 05/02/2019] Trial Registered Prospectively
Last Modified On: 22/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to evaluate the pain relieving effect of medicated enema and medicated purgation in the management of joint pain 
Scientific Title of Study   A comparative study to evaluate the Rujahara(analgesic) effect of virechana karma and vaitarana basti in Amavata (rheumatoid arthritis)  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Divya Gupta 
Designation  PG scholar 
Affiliation  CHAUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, KHERA DABAR, NEW DELHI 
Address  PG DOCTORS HOSTEL, CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN,Panchkarma department room no 231 KHERA DABAR, NEW DELHI
PG DOCTORS HOSTEL, CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, Panchkarma department room no 231 KHERA DABAR, NEW DELHI
South West
DELHI
110073
India 
Phone  9460044624  
Fax    
Email  drdivya.rsg93@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vishakha R Wetal 
Designation  Associate professor 
Affiliation  CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, KHERA DABAR, NEW DELHI 
Address  CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, panchkarma department room no 231 KHERA DABAR, NEW DELHI
CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, panchkarma department room no 231 KHERA DABAR, NEW DELHI
South West
DELHI
110073
India 
Phone  9850804498  
Fax    
Email  vishakhawetal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vishakha R Wetal 
Designation  Associate professor 
Affiliation  CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN, KHERA DABAR, NEW DELHI 
Address  CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN,panchkarma department room no 231 KHERA DABAR, NEW DELHI
CHOUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN,panchkarma department room no 231 KHERA DABAR, NEW DELHI
South West
DELHI
110073
India 
Phone  9850804498  
Fax    
Email  vishakhawetal@gmail.com  
 
Source of Monetary or Material Support  
chaudhary brahm prakash ayurveda charak sansthan khera dabar 
 
Primary Sponsor  
Name  Choudhary brahm prakash charak ayurveda sansthana 
Address  Choudhary brahm prakash charak ayurveda sansthana,khera dabar najafgarh new delhi 110073 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
divya gupta  chaudhary brahm prakash ayurveda charak sansthana  PG DOCTORS HOSTEL CHAUDHARY BRAHM PRAKASH AYURVED CHARAK SANSTHAN panchkarma department room no 231 KHERA DABAR Najafgarh NEW DELHI 110073
South West
DELHI 
7062847624

drdivya.rsg93@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics committee-Choudhary brahm prakash ayurveda charak sansthan  Approved 
Institutional Ethics committee-Choudhary brahm prakash ayurveda charak sansthan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Vaitarana basti  Vaitarana basti will be administered for 8 days in the sequence of Yoga basti,450 ml daily 
Intervention  Virechana karma with Trivritadi churna  Virechana karma with Trivritadi churna as per koshtha and Agni In pitta kala 1 day  
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients with clinical features of Amavata as described in Madhav Nidan.
Patients between the age group of 21 to 50 years.
Patients fulfilling the 2010 ACR-EULAR criteria for Rheumatoid Arthritis.
 
 
ExclusionCriteria 
Details  Patients having severe crippling bone deformities and severely damaged joint with bed ridden patients.
Patients having any type of Arthropathy such as neoplasm of spine, Gout, Ankylosing spondylitis, Traumatic arthritis and pyogenic osteomyelitis and any other type of arthritis.
Patients having associated Cardiac disease, Tuberculosis, malignant hypertension, Impairment of Liver functions, Impairment of Renal functions, malignancy, HIV-AIDS etc.
Pregnant women and lactating mother.

Patients who develop secondary complication of RA e.g. Pleuro-pericardial diseases
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
improvement in DAS28 (disease activity score 28)  16 day 
 
Secondary Outcome  
Outcome  TimePoints 
PAIN IN JOINTS(VAS)SCALE  16 DAY 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   08/02/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This study is a open label parallel group trial comparing the efficacy of Vaitaran basti (medicated enema) and Virechana karma in the management of Amavata (Rheumatoid Arthritis) In one group Vaitaran basti in the dose of 450 ml per day for 8 days will be given. In another group virechana karma will be given. The trial will be conducted in Chaudhary Brahm Prakash Ayurved Charak
Sansthan India with primary outcome of improvement in Disease activity score  and secondary outcome of improvement in Visual analouge scale .
 
Close